Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - azathioprine, quantity: 50 mg - tablet, film coated - excipient ingredients: magnesium stearate; colloidal anhydrous silica; titanium dioxide; lactose monohydrate; maize starch; purified talc; povidone; hypromellose; microcrystalline cellulose; peg-8 stearate - immunosuppressant antimetabolite: either alone, or more commonly, in combination with other agents (usually corticosteroids) and procedures which influence the immune response. therapeutic effect may be evident only after weeks or months and can include a steroid-sparing effect, thereby reducing the toxicity associated with higher dosage and prolonged usage of corticosteroids. azathioprine, in combination with cortocosteroids and/or other immunosuppressive agents and procedures, is indicated in the management of patients receiving organ transplants. azathioprine, either alone or more usually in combination with corticosteroids and/or other procedures, has been used with clinical benefit which may include reduction of dosage or discontinuation of corticosteroids, in a proportion of patients suffering from the following: severe rheumatoid arthritis, systemic lupus erythematosus, dermatomyositis/polymyositis, autoimmune chronic active hepatitis, pemphigus vulgaris, polyarteritis nodosa, autoimmune haemolytic anaemia, chronic refractory idiopathic thrombocytopenic purpura.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - azathioprine, quantity: 25 mg - tablet, film coated - excipient ingredients: purified talc; lactose monohydrate; magnesium stearate; maize starch; povidone; colloidal anhydrous silica; titanium dioxide; hypromellose; microcrystalline cellulose; peg-8 stearate - immunosuppressant antimetabolite: either alone, or more commonly, in combination with other agents (usually corticosteroids) and procedures which influence the immune response. therapeutic effect may be evident only after weeks or months and can include a steroid-sparing effect, thereby reducing the toxicity associated with higher dosage and prolonged usage of corticosteroids. azathioprine, in combination with cortocosteroids and/or other immunosuppressive agents and procedures, is indicated in the management of patients receiving organ transplants. azathioprine, either alone or more usually in combination with corticosteroids and/or other procedures, has been used with clinical benefit which may include reduction of dosage or discontinuation of corticosteroids, in a proportion of patients suffering from the following: severe rheumatoid arthritis, systemic lupus erythematosus, dermatomyositis/polymyositis, autoimmune chronic active hepatitis, pemphigus vulgaris, polyarteritis nodosa, autoimmune haemolytic anaemia, chronic refractory idiopathic thrombocytopenic purpura.

Australia - English - Department of Health (Therapeutic Goods Administration)

jace pharma pty ltd - trientine tetrahydrochloride, quantity: 300 mg (equivalent: trientine, qty 150 mg) - tablet, film coated - excipient ingredients: purified talc; glycerol dibehenate; colloidal anhydrous silica; mannitol; titanium dioxide; iron oxide yellow; polyglycerol esters of fatty acids; sodium lauryl sulfate; polyvinyl alcohol - cuprior is indicated for the treatment of wilson?s disease in adults, adolescents and children ? 5 years intolerant to d-penicillamine therapy.

Ireland - English - HPRA (Health Products Regulatory Authority)

alliance pharmaceuticals ltd. - penicillamine - film coated tablet - 250 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

mercury pharmaceuticals ltd - auranofin - film coated tablet - 3 milligram

Australia - English - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - auranofin, quantity: 3 mg - tablet, film coated - excipient ingredients: titanium dioxide; maize starch; lactose monohydrate; magnesium stearate; iron oxide yellow; microcrystalline cellulose; hypromellose; purified water; sodium starch glycollate; propylene glycol; ethanol - indications as at 14 november 2000: adjunctive treatment of active classical or definite rheumatoid arthritis in adults who have an insufficient therapeutic response to, or are intolerant of, an adequate trial of a baseline therapeutic program, including among other measures, full doses of one or more non-steroidal anti-inflammatory drugs. ridaura is not indicated in non-rheumatoid arthropathies such as osteoarthrosis. ridaura should be added to a comprehensive baseline therapeutic program.

Ireland - English - HPRA (Health Products Regulatory Authority)

clear pharma limited - azathioprine - film coated tablet - 50 milligram - other immunosuppressants

Ireland - English - HPRA (Health Products Regulatory Authority)

b & s healthcare - azathioprine - film coated tablet - 50 milligram - other immunosuppressants

Ireland - English - HPRA (Health Products Regulatory Authority)

mercury pharmaceuticals ltd - auranofin - film coated tablet - 3 milligram

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - penicillamine, quantity: 250 mg - tablet, film coated - excipient ingredients: magnesium stearate; povidone; carnauba wax; sodium starch glycollate type a; ethanol; chloroform; lactose monohydrate; isopropyl alcohol; titanium dioxide; hypromellose; macrogol 400